栄研化学の株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2024/09/09 | 2,294 | 2,339 | 2,277 | 2,323 | -3 | -0.1% | 45,600 |
| 2024/09/06 | 2,298 | 2,332 | 2,286 | 2,326 | +48 | +2.1% | 51,600 |
| 2024/09/05 | 2,300 | 2,329 | 2,268 | 2,278 | -37 | -1.6% | 64,200 |
| 2024/09/04 | 2,288 | 2,324 | 2,281 | 2,315 | +11 | +0.5% | 92,000 |
| 2024/09/03 | 2,297 | 2,320 | 2,285 | 2,304 | +33 | +1.5% | 49,900 |
| 2024/09/02 | 2,289 | 2,305 | 2,256 | 2,271 | -25 | -1.1% | 46,500 |
| 2024/08/30 | 2,296 | 2,306 | 2,253 | 2,296 | +39 | +1.7% | 92,600 |
| 2024/08/29 | 2,287 | 2,306 | 2,239 | 2,257 | -17 | -0.7% | 107,200 |
| 2024/08/28 | 2,238 | 2,287 | 2,238 | 2,274 | -4 | -0.2% | 32,700 |
| 2024/08/27 | 2,280 | 2,301 | 2,258 | 2,278 | +25 | +1.1% | 62,100 |
| 2024/08/26 | 2,273 | 2,283 | 2,252 | 2,253 | -20 | -0.9% | 48,400 |
| 2024/08/23 | 2,285 | 2,289 | 2,250 | 2,273 | -11 | -0.5% | 44,300 |
| 2024/08/22 | 2,266 | 2,293 | 2,261 | 2,284 | +31 | +1.4% | 39,400 |
| 2024/08/21 | 2,224 | 2,253 | 2,206 | 2,253 | +13 | +0.6% | 58,000 |
| 2024/08/20 | 2,255 | 2,276 | 2,223 | 2,240 | -7 | -0.3% | 59,000 |
| 2024/08/19 | 2,316 | 2,350 | 2,247 | 2,247 | -67 | -2.9% | 94,900 |
| 2024/08/16 | 2,256 | 2,314 | 2,236 | 2,314 | +82 | +3.7% | 109,100 |
| 2024/08/15 | 2,246 | 2,246 | 2,207 | 2,232 | +32 | +1.5% | 66,600 |
| 2024/08/14 | 2,157 | 2,222 | 2,157 | 2,200 | +34 | +1.6% | 102,800 |
| 2024/08/13 | 2,150 | 2,197 | 2,143 | 2,166 | +36 | +1.7% | 68,900 |
| 2024/08/09 | 2,150 | 2,194 | 2,089 | 2,130 | +30 | +1.4% | 94,400 |
| 2024/08/08 | 2,064 | 2,129 | 2,056 | 2,100 | -14 | -0.7% | 114,500 |
| 2024/08/07 | 2,090 | 2,181 | 2,067 | 2,114 | +23 | +1.1% | 150,100 |
| 2024/08/06 | 1,993 | 2,104 | 1,960 | 2,091 | +212 | +11.3% | 136,300 |
| 2024/08/05 | 1,967 | 2,024 | 1,849 | 1,879 | -220 | -10.5% | 129,500 |
| 2024/08/02 | 2,157 | 2,216 | 2,056 | 2,099 | -56 | -2.6% | 308,200 |
| 2024/08/01 | 2,245 | 2,266 | 2,140 | 2,155 | -290 | -11.9% | 216,900 |
| 2024/07/31 | 2,430 | 2,445 | 2,407 | 2,445 | +8 | +0.3% | 135,200 |
| 2024/07/30 | 2,458 | 2,468 | 2,422 | 2,437 | -7 | -0.3% | 82,200 |
| 2024/07/29 | 2,409 | 2,453 | 2,389 | 2,444 | +60 | +2.5% | 103,700 |
| 2024/07/26 | 2,383 | 2,398 | 2,378 | 2,384 | -28 | -1.2% | 81,000 |
| 2024/07/25 | 2,373 | 2,420 | 2,346 | 2,412 | +14 | +0.6% | 96,800 |
| 2024/07/24 | 2,373 | 2,422 | 2,373 | 2,398 | +33 | +1.4% | 111,400 |
| 2024/07/23 | 2,347 | 2,382 | 2,328 | 2,365 | +32 | +1.4% | 49,100 |
| 2024/07/22 | 2,345 | 2,345 | 2,309 | 2,333 | -19 | -0.8% | 39,400 |
| 2024/07/19 | 2,349 | 2,363 | 2,332 | 2,352 | -2 | -0.1% | 98,700 |
| 2024/07/18 | 2,366 | 2,406 | 2,353 | 2,354 | -32 | -1.3% | 121,800 |
| 2024/07/17 | 2,393 | 2,400 | 2,349 | 2,386 | +6 | +0.3% | 138,500 |
| 2024/07/16 | 2,390 | 2,395 | 2,363 | 2,380 | +6 | +0.3% | 98,900 |
| 2024/07/12 | 2,311 | 2,374 | 2,311 | 2,374 | +41 | +1.8% | 91,800 |
| 2024/07/11 | 2,311 | 2,358 | 2,309 | 2,333 | +33 | +1.4% | 77,300 |
| 2024/07/10 | 2,275 | 2,300 | 2,267 | 2,300 | +19 | +0.8% | 74,700 |
| 2024/07/09 | 2,249 | 2,290 | 2,245 | 2,281 | +32 | +1.4% | 101,100 |
| 2024/07/08 | 2,240 | 2,262 | 2,236 | 2,249 | +29 | +1.3% | 116,300 |
| 2024/07/05 | 2,210 | 2,220 | 2,208 | 2,220 | +10 | +0.5% | 29,800 |
| 2024/07/04 | 2,206 | 2,220 | 2,191 | 2,210 | +14 | +0.6% | 71,400 |
| 2024/07/03 | 2,202 | 2,211 | 2,179 | 2,196 | -6 | -0.3% | 62,000 |
| 2024/07/02 | 2,192 | 2,210 | 2,174 | 2,202 | +20 | +0.9% | 73,100 |
| 2024/07/01 | 2,241 | 2,241 | 2,177 | 2,182 | -58 | -2.6% | 63,800 |
| 2024/06/28 | 2,250 | 2,250 | 2,204 | 2,240 | +20 | +0.9% | 103,100 |
51～
100
件表示中 / 6840件
類似銘柄と比較する
現在ご覧いただいている「栄研化」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 栄研化 | 209,200円 | +0.4% | -8.4% | 2.53% | 27.65倍 | 1.57倍 |
|
臨床検査薬大手。便潜血検査試薬（ＦＩＴ）はシェア７割。尿検査（ウロ）、遺伝子検査も育成 |
| 杏林製薬 | 149,900円 | +3.2% | +4.5% | 3.47% | 17.22倍 | 0.66倍 |
|
医薬中堅。柱のぜんそく薬、呼吸器アレルギー薬は下期に比重。消化器領域育成。後発品も |
| ＪＣＲファーマ | 72,400円 | -3.7% | -36.7% | 2.76% | 23.84倍 | 1.56倍 |
|
ヒト成長ホルモン製剤が主力、バイオ後続品も成長。希少疾病のバイオ新薬開発にも取り組む |
| サンバイオ | 96,500円 | - | - | 0.00% | - | 48.59倍 |
|
脳疾患向け再生細胞薬の開発・製造・販売目指すバイオベンチャー。米国で創業し日本に逆上陸 |
| あすかＨＤ | 203,600円 | +0.3% | +2.7% | 2.46% | 11.55倍 | 0.90倍 |
|
武田と親密。婦人科領域に強い。先発品比率引き上げに注力。２１年春にあすか製薬が持株会社化 |
市場注目の銘柄
チャート関連のコラム
